By Devika Patel
Knoxville, Tenn., July 25 - Optimer Pharmaceuticals, Inc. will take in $14.78 million in a private placement of shares, according to a prospectus supplement filed Friday with the Securities and Exchange Commission.
The company will sell 1,743,396 common shares at $8.48 per share.
Settlement is expected July 28.
Proceeds will be used to fund clinical and pre-clinical development of the company's product candidates and for general corporate purposes. Optimer may also use a portion of the proceeds to acquire or invest in businesses, products and technologies.
San Diego-based Optimer Pharmaceuticals is a biopharmaceutical company specializing on the discovering, developing and commercializing of innovative treatments.
| Issuer: | Optimer Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $14,783,998.08
|
| Shares: | 1,743,396
|
| Price: | $8.48
|
| Warrants: | No
|
| Pricing date: | July 25
|
| Settlement date: | July 28
|
| Stock symbol: | Nasdaq: OPTR
|
| Stock price: | $8.28 at close July 24
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
